Pharmacometrics Africa is a platform for interested groups to establish and run open access quantitative clinical pharmacology educational programs in partnership with local research organisations and academic groups.
Pharmacometrics is an emerging discipline that uses mathematical and statistical tools to quantify drug, disease, and trial information to aid efficient drug development and/or regulatory decisions. It designs and applies mathematical models to describe the relationship between drug exposure (pharmacokinetics) and response (pharmacodynamics) for both desired and undesired effects, and aims to include in such models the effects of individual patient characteristics.
To help address the critical skills gap in regulatory sciences on the African continent, Pharmacometrics Africa hosted a 12-week course for participants from three regulatory agencies in July 2021. The learnings, evaluations and structure of this course have been summarised in the Pilot Project Summary and Report that you can download below.
This tailored workshop on in vitro-in vivo extrapolation of metabolism, transport, and biopharmaceutics included hands-on exercises using the industry standard Simcyp Population-based Simulator for PBPK modeling, formulation development, and DDI predictions.
“Capacity building programmes for African regulators should link education, training and research with career development in an approach that combines an academic base and experiential
Delegates at WCoP2022 witnessed first-hand the potential for expanding clinical research and the science of pharmacometrics in Africa. We were especially proud to showcase the results of the capability and capacity strengthening efforts for clinical pharmacology and pharmacometrics that were funded by the Foundation under this grant.
Application deadline: Monday 2 November 2020 Thank you to all who applied so far for our Clinical Pharmacology and Pharmacometrics
As part of our commitment to supporting the African clinical care and research community through the COVID-19 pandemic, Pharmacometrics…
